Dries Reynders
- Work address
-
Krijgslaan 281, S9
9000 Gent - Dries.Reynders@UGent.be
Show
Sort by
-
Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy
-
Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer
-
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results
-
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
-
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
-
- Journal Article
- A1
- open access
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer reply
-
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
-
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
-
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
-
- Journal Article
- A1
- open access
Standardization of free thyroxine measurements allows the adoption of a more uniform reference interval